Unusually Long Survival from Diagnosis (More Than Three Years to More Than 29 Years) in 27 Glioblastoma Patients Treated with Antineoplastons in Phase II Studies
Stanislaw R Burzynski, Gregory S Burzynski, Tomasz J Janicki, Radoslaw J Siwiec, Samuel W Beenken
Rec. Date:
2025-08-30
Acc. Date:
2025-09-08
Pub. Date:
2025-09-12
